CBIS PRODUCT PIPELINE.

CBIS Cannabinoid research and development focuses on pharmaceutical distribution, as well as other specific markets. Our main target markets include FDA doctor-written prescriptions targeting critical ailments such as Cancer; HIV/AIDS; Epilepsy; Chronic Pain; Arthritis; Autism; Parkinson’s Disease and PTSD, Over-the-Counter markets including nutraceuticals and cosmeceuticals, and State by State Initiatives including regulation; cultivation; laboratories; manufacturing; and distribution. Research is currently being conducted in laboratories globally, and with multiple University partnerships.

CLINICAL DRUG DEVELOPMENT

OVER THE COUNTER

STATE BY STATE